H. Butzkueven Et Al. , "Real-world experience with ocrelizumab in relapsing multiple sclerosis: insights from the MSOCR-R cohort, an MSBase registry sub-study," MULTIPLE SCLEROSIS JOURNAL , vol.27, no.2_SUPPL, pp.104-106, 2021
Butzkueven, H. Et Al. 2021. Real-world experience with ocrelizumab in relapsing multiple sclerosis: insights from the MSOCR-R cohort, an MSBase registry sub-study. MULTIPLE SCLEROSIS JOURNAL , vol.27, no.2_SUPPL , 104-106.
Butzkueven, H., Spelman, T., Ozakbas, S., Boz, C., Buzzard, K., Skibina, O., ... Kalincik, T.(2021). Real-world experience with ocrelizumab in relapsing multiple sclerosis: insights from the MSOCR-R cohort, an MSBase registry sub-study. MULTIPLE SCLEROSIS JOURNAL , vol.27, no.2_SUPPL, 104-106.
Butzkueven, H. Et Al. "Real-world experience with ocrelizumab in relapsing multiple sclerosis: insights from the MSOCR-R cohort, an MSBase registry sub-study," MULTIPLE SCLEROSIS JOURNAL , vol.27, no.2_SUPPL, 104-106, 2021
Butzkueven, H. Et Al. "Real-world experience with ocrelizumab in relapsing multiple sclerosis: insights from the MSOCR-R cohort, an MSBase registry sub-study." MULTIPLE SCLEROSIS JOURNAL , vol.27, no.2_SUPPL, pp.104-106, 2021
Butzkueven, H. Et Al. (2021) . "Real-world experience with ocrelizumab in relapsing multiple sclerosis: insights from the MSOCR-R cohort, an MSBase registry sub-study." MULTIPLE SCLEROSIS JOURNAL , vol.27, no.2_SUPPL, pp.104-106.
@article{article, author={H. Butzkueven Et Al. }, title={Real-world experience with ocrelizumab in relapsing multiple sclerosis: insights from the MSOCR-R cohort, an MSBase registry sub-study}, journal={MULTIPLE SCLEROSIS JOURNAL}, year=2021, pages={104-106} }